1. Human Herpesvirus 8/Kaposi Sarcoma Herpesvirus Cell Association During Evolution of Kaposi Sarcoma
- Author
-
Thomas Heiden, Esmeralda Castaños-Velez, Ephata E. Kaaya, Charles Massambu, Susanna Ericsson, Peter Biberfeld, and Pawan Pyakurel
- Subjects
Pathology ,medicine.medical_specialty ,CD3 Complex ,viruses ,CD3 ,Population ,CD34 ,Antigens, Differentiation, Myelomonocytic ,Antigens, CD34 ,medicine.disease_cause ,Herpesviridae ,Antigen ,Antigens, CD ,medicine ,Humans ,Gammaherpesvirinae ,Pharmacology (medical) ,education ,Antigens, Viral ,Sarcoma, Kaposi ,CD20 ,Acquired Immunodeficiency Syndrome ,education.field_of_study ,biology ,CD68 ,Nuclear Proteins ,virus diseases ,biochemical phenomena, metabolism, and nutrition ,Antigens, CD20 ,biology.organism_classification ,Molecular biology ,Ki-67 Antigen ,Infectious Diseases ,Herpesvirus 8, Human ,biology.protein ,Leukocyte Common Antigens - Abstract
Kaposi sarcoma (KS) is associated with a herpesvirus (HHV-8/KSHV), which expresses a latency-associated nuclear antigen (LANA). The histopathology of KS is characterized by angiogenesis, inflammatory cells, and the development of CD34 + tumor spindle cells (SCs). However, the cellular basis for the recruitment and dissemination of HHV-8 during the development of KS lesions is not clear. Twenty-nine KS biopsies with AIDS (AKS, n = 22) and without HIV infection (endemic KS or EKS, n = 7) were immunostained by a triple antibody method to characterize HHV-8-infected and noninfected (LANA +/- ) CD34 + SCs, infiltrating CD 3+ , CD68 + , CD20 + , and CD45 + leukocytes as well as proliferating (Ki67 + ) cells. The CD34 + /LANA + SCs were more frequent in late (nodular) as compared with early (patch/plaque) KS stages. However, in late AKS 36.0% of SCs (median of 11 cases) were CD34 + /LANA - compared with 20.7% in early cases (median of 11 cases). Furthermore, both AKS and EKS showed, at all stages, a small (4.1-6.5%) population of LANA + /CD34 - cells. Proliferating Ki67 + cells were seen (4.5-11.5%) at all KS stages, and were usually more frequent in early AKS, but no significant difference was observed between nodular AKS and EKS. Most of the proliferating cells in the KS lesions were LANA + /CD34 + but a small fraction was LANA + /CD34. Lesional CD68 + and CD3 + cells varied between AKS (7.3 and 5.2%, respectively) and EKS (4.9 and 3.1%, respectively) but were not clearly stage related. No LANA + cells were CD3 + , CD20 + , or CD45' and very few (
- Published
- 2004
- Full Text
- View/download PDF